Health Care: Drugs

OxiGene Inc (OXGN: NASDAQ)

$2.38 0.1 | 4.39%
08/29/14 - 04:00 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -8.28M -8.08M 0.00 -23.77M
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00 0.00 0.00
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 65.00K
(Decrease) Increase In Payables 350.00K -1.35M -956.00K -4.34M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 20.00K 0.00 55.00K 0.00
Other Non-Cash Items 679.00K 505.00K -11.02M 6.97M
Net Cash From Continuing Operations -7.00M -8.34M -11.78M -20.43M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -7.00M -8.34M -11.78M -20.43M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -35.00K 0.00 0.00 0.00
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 -8.00K 0.00 3.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -35.00K -8.00K 0.00 3.00K
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 864.00K 3.32M 17.15M 11.04M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 8.23M 0.00 0.00 50.00K
Net Cash From Financing Activities 9.10M 3.32M 17.15M 11.09M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 2.06M -5.03M 5.37M -9.33M

Portfolios with OXGN

Latest OXGN Headlines from TheStreet

More Financial News for OXGN

Press Releases for OXGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter